MCKESSON CORPORATION |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 518.8 USD | -1.35% |
|
-0.87% | +12.06% |
| Apr. 18 | Nephron Research Raises McKesson's Price Target to $600 From $530 | MT |
| Apr. 15 | Morgan Stanley Adjusts Price Target on McKesson to $548 From $522 | MT |
ETFs positioned on McKesson Corporation
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 2.31% | 1,026 M€ | +6.11% | - | |
| 1.18% | 204 M€ | +10.54% | ||
| 1.08% | 18 M€ | +2.91% | - | |
| 0.67% | 3 M€ | +15.16% | - | |
| 0.67% | 4 M€ | -.--% | - | |
| 0.67% | 13 M€ | -.--% | - | |
| 0.61% | 10 M€ | +3.30% | ||
| 0.60% | 9 M€ | -.--% | - | |
| 0.58% | 5 M€ | -.--% | - | |
| 0.50% | 5 M€ | -72.95% | - | |
| 0.35% | 1,174 M€ | +23.54% | ||
| 0.35% | 655 M€ | -.--% | - | |
| 0.35% | 273 M€ | -.--% | ||
| 0.34% | 393 M€ | +3.61% | ||
| 0.32% | 205 M€ | -.--% | ||
| 0.29% | 26 M€ | +16.85% | - | |
| 0.21% | 1 M€ | +0.04% | ||
| 0.20% | 27 M€ | +14.02% | - | |
| 0.18% | 9 M€ | +2.11% | - | |
| 0.18% | 736 M€ | +5.73% |
McKesson Corporation specializes in pharmaceutical product distribution. The group also offers technological services to healthcare companies. Net sales break down by activity as follows:
- distribution of pharmaceutical products (87%);
- distribution of medical and surgical products (4%);
- other (1.6%): primarily technology services and software sales.
The remaining net sales (7.4%) are from international activities.
Sector
Pharmaceuticals
Calendar
2024-05-07
- Q4 2024 Earnings Release
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
C+
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
19
Last Close Price
525.9
USD
Average target price
559.5
USD
Spread / Average Target
+6.39%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +12.06% | 69.11B | |
| +5.16% | 25.91B | |
| +4.48% | 8.01B | |
| -3.28% | 7.91B | |
| -23.97% | 7.27B | |
| -0.67% | 4.51B | |
| +20.68% | 4.48B | |
| -4.23% | 3.95B | |
| -3.99% | 3.79B | |
| +23.62% | 3.7B |
- Stock Market
- Equities
- MCK Stock
- Funds and ETFs McKesson Corporation
